Allianz Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Allianz Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$978K	Hold	70,595	–	–	﹤0.01%	1717
2025 Q4	$991K	Hold	70,595	–	–	﹤0.01%	1711
2025 Q3	$987K	Sell	70,595 -370,856	-84%	-$5.34M	﹤0.01%	1716
2025 Q2	$6.64M	Buy	441,451 +120,180	+37%	+$1.72M	0.01%	971
2025 Q1	$4.24M	Sell	321,271 -154,178	-32%	-$2.13M	0.01%	1198
2024 Q4	$7.51M	Buy	475,449 +230,714	+94%	+$3.47M	0.01%	863
2024 Q3	$3.89M	Sell	244,735 -14,110	-5%	-$227K	0.01%	1162
2024 Q2	$3.94M	Buy	258,845 +10,035	+4%	+$144K	0.01%	1064
2024 Q1	$3.65M	Buy	248,810 +25,725	+12%	+$376K	0.01%	975
2023 Q4	$3.1M	Sell	223,085 -12,215	-5%	-$163K	0.01%	1135
2023 Q3	$3.15M	Buy	235,300 +16,680	+8%	+$226K	0.01%	1207
2023 Q2	$2.76M	Buy	218,620 +142,785	+188%	+$1.67M	﹤0.01%	1136
2023 Q1	$863K	Buy	+75,835	New	+$819K	﹤0.01%	1748
2022 Q1	–	Sell	-18,375	Closed	-$240K	–	2610
2021 Q4	$240K	Sell	18,375 -14,380	-44%	-$181K	﹤0.01%	2430
2021 Q3	$427K	Buy	32,755 +875	+3%	+$11.7K	﹤0.01%	2285
2021 Q2	$469K	Buy	31,880 +605	+2%	+$8.46K	﹤0.01%	2059
2021 Q1	$384K	Sell	31,275 -26,810	-46%	-$344K	﹤0.01%	1987
2020 Q4	$828K	Sell	58,085 -10,090	-15%	-$136K	﹤0.01%	1531
2020 Q3	$949K	Sell	68,175 -22,935	-25%	-$273K	﹤0.01%	1441
2020 Q2	$966K	Buy	91,110 +13,185	+17%	+$134K	﹤0.01%	1835
2020 Q1	$629K	Buy	+77,925	New	+$650K	﹤0.01%	1967
2019 Q3	–	Sell	-32,500	Closed	-$244K	–	2791
2019 Q2	$244K	Sell	32,500 -83,660	-72%	-$658K	﹤0.01%	2555
2019 Q1	$941K	Hold	116,160	–	–	﹤0.01%	2124
2018 Q4	$876K	Sell	116,160 -8,000	-6%	-$56.3K	﹤0.01%	2077
2018 Q3	$859K	Buy	124,160 +45,500	+58%	+$304K	﹤0.01%	2269
2018 Q2	$507K	Buy	78,660 +6,000	+8%	+$37.8K	﹤0.01%	2389
2018 Q1	$475K	Hold	72,660	–	–	﹤0.01%	2393
2017 Q4	$546K	Hold	72,660	–	–	﹤0.01%	2398
2017 Q3	$519K	Sell	72,660 -117,455	-62%	-$844K	﹤0.01%	2403
2017 Q2	$1.6M	Buy	190,115 +7,055	+4%	+$57.4K	﹤0.01%	2062
2017 Q1	$1.47M	Buy	183,060 +54,000	+42%	+$466K	﹤0.01%	2107
2016 Q4	$1.17M	Buy	129,060 +26,840	+26%	+$250K	﹤0.01%	2165
2016 Q3	$948K	Sell	102,220 -319,660	-76%	-$3.05M	﹤0.01%	2225
2016 Q2	$4.32M	Sell	421,880 -354,500	-46%	-$3.25M	﹤0.01%	1574
2016 Q1	$7.02M	Sell	776,380 -229,775	-23%	-$2.05M	0.01%	1307
2015 Q4	$9.31M	Buy	1,006,155 +428,445	+74%	+$4.69M	0.01%	1086
2015 Q3	$7.38M	Buy	577,710 +38,520	+7%	+$478K	0.01%	1115
2015 Q2	$5.97M	Buy	539,190 +76,950	+17%	+$850K	0.01%	1323
2015 Q1	$5.28M	Buy	462,240 +90,525	+24%	+$960K	0.01%	1199
2014 Q4	$3.75M	Sell	371,715 -32,540	-8%	-$343K	﹤0.01%	1317
2014 Q3	$4.25M	Sell	404,255 -225,360	-36%	-$2.12M	0.01%	1144
2014 Q2	$5.43M	Sell	629,615 -139,955	-18%	-$1.18M	0.01%	912
2014 Q1	$6.75M	Buy	769,570 +319,475	+71%	+$2.78M	0.01%	866
2013 Q4	$3.69M	Buy	450,095 +110,095	+32%	+$871K	﹤0.01%	1034
2013 Q3	$2.34M	Buy	340,000 +227,000	+201%	+$1.65M	﹤0.01%	1146
2013 Q2	$855K	Buy	+113,000	New	+$825K	﹤0.01%	1382

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Allianz Asset Management's RDY Position: Q1 2026 in Review

Allianz Asset Management held its Dr. Reddy's Laboratories (RDY) position steady in Q1 2026 at 70,595 shares worth $978K. The position accounts for ﹤0.01% of the portfolio, ranked #1717.

Allianz Asset Management first reported a position in RDY in Q2 2013 and has held it in 46 quarters since. The position peaked at $9.31M in Q4 2015. 249 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

Allianz Asset Management held 70,595 shares of Dr. Reddy's Laboratories worth $978K as of Q1 2026.
Allianz Asset Management left its Dr. Reddy's Laboratories share count unchanged in Q1 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of Allianz Asset Management's portfolio in Q1 2026, its #1717 holding.
Allianz Asset Management first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 46 quarters since.
Allianz Asset Management's Dr. Reddy's Laboratories position peaked at $9.31M in Q4 2015.
249 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.